University of Iowa Research Foundation received U.S. patents for CMV promoter
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
On Oct. 9, 1991, Bristol-Myers’ VIDEX (didanosine) was approved by the U.S. Food and Drug Administration for the…
On Aug. 26, 1991, Cellpro announced its initial public offering. CellPro, founded in Bothell, Washington, developed the CEPRATE…
On Jun. 6, 1991, ICOS completed its IPO at at $8.00 per share for a total of $36…
On Mar. 6, 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market…
On Feb. 22, 1991, the Food and Drug Administration (FDA) announced that it had approved Amgen’s two white…
In 1991, the policy for protection of human subjects in research, promulgated in 1981 by the U.S. Food…
In 1991, the U.S. Food and Drug Administration (FDA) published regulations to Accelerate the Review of Drugs for life-threatening diseases….
In 1991, Bristol Myers Squibb’s cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) were approved by the…
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
On Nov. 28, 1990, the Safe Medical Devices Act was passed, requiring nursing homes, hospitals, and other facilities…
On Nov. 8, 1990, the Nutrition Labeling and Education Act (NLEA) was signed into law by President George…
On Apr. 13, 1990, the Immunization Practices Advisory Committee (ACIP) recommendations for use of any of the three…
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
On Nov. 24, 1989, the U.S. Food and Drug Administration (FDA) issued a nationwide recall of all over-the-counter…
On Aug. 28, 1989, a second recombinant hepatitis B vaccine, Engerix-B (SmithKlineBeecham), was approved for use in the…
On Jun. 1, 1989, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…
On Mar. 3, 1989, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers’ PARAPLATIN (carboplatin) for the treatment…
In 1989, transgenic fast-growing salmon were created. In 2015, the U.S. Food and Drug Administration (FDA) approved a…
In 1989, CellPro was founded in Bothell as a spin-off from the Fred Hutchinson Cancer Research Center. The…
On Jan. 1, 1989, Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized in gene therapy, a…
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
On Apr. 22. 1988, the Prescription Drug Marketing Act of 1987 (PDMA) was signed into law by the…
In 1988, Dr. Fletcher Taylor and Dr. Charles Esmon from the Oklahoma Medical Research Foundation (OMRF) filed for…
In 1988, the Food and Drug Administration Act by the U.S. Congress officially established the U.S. Food and…
In 1988, the U.S. Food and Drug Administration (FDA) published a final rule, Annual Summary Reporting Requirements Under the…
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
In December 1987, the antidepressant fluoxetine (Prozac), discovered by David T. Wong, received U.S. Food and Drug Administration…
On Oct. 6, 1987, the Center for Drugs and Biologics within the U.S. Food and Drug Administration was…